Intracardiac thrombosis in Behcet disease: Clinical presentation and outcome of three cases

被引:9
作者
Khammar, Z. [1 ]
Berrady, R. [1 ]
Boukhrissa, A. [1 ]
Lamchachti, L. [1 ]
Amrani, K. [1 ]
Rabhi, S. [1 ]
Bono, W. [1 ]
机构
[1] CHU Hassan II, Serv Med Interne, Fes 30000, Morocco
关键词
Intracardiac thrombosis; Behcet's disease; Anticoagulant therapy; RIGHT HEART;
D O I
10.1016/j.jmv.2011.04.002
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background. - Behcet's disease is recognized as a multisystem disorder that affects mainly young adults in Mediterranean, Middle Eastern, and Far Eastern countries. The diagnosis is very difficult because there is no laboratory test. Clinical features - such as orogenital aphtae, ocular and skin lesions, arthritis, and neurologic, gastrointestinal, vascular, and pulmonary symptoms - are helpful for diagnosis. Various cardiovascular manifestations, such as pancarditis, acute myocardial infarction, conduction system disturbances, and valvular diseases, have been reported but are rare. Intracardiac thrombus formation, as seen in our patients, is exceptional even among cardiovascular cases of Behcet's. Observations. - We report three cases of intracardiac thrombosis among 204 patients followed for Behcet's disease within our unit over a period of 7 years. We report outcomes after corticosteroid, cyclophosphamide, and oral anticoagulant therapy. Discussion. - Cardiovascular involvement has been reported in 7% to 29% of patients with Behcet's syndrome. Intracardiac thrombosis is extremely rare and the right heart is the most common site of involvement. The first symptoms and signs of the disease frequently precede systemic organ manifestations. Conclusion. - Diagnosis of Behcet's disease might be considered if a patient presents with a mass in the right-sided cardiac chambers, even in the absence of the characteristic clinical features of the condition. This is particularly applicable if the patient is a young male from the Mediterranean basin or the Middle East. We suggest that the treatment could include colchicine, anticoagulant therapy, and corticosteroids and discuss immunosuppressive therapy. (C) 2011 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:270 / 273
页数:4
相关论文
共 11 条
[1]   Cardiac and arterial pulmonary disorders in the course of Behcet's disease [J].
Bono, W ;
Filali-Ansary, N ;
Mohattane, A ;
Tazi-Mezalek, Z ;
Adnaoui, M ;
Aouni, M ;
Maaouni, A ;
Berbich, A .
REVUE DE MEDECINE INTERNE, 2000, 21 (10) :905-907
[2]  
BORSONCHAZOT F, 1999, ACT MED INT, V111, P31
[3]  
BUGE A, 1977, ANN MED INTERNE, V128, P411
[4]  
Cemri M, 2002, Eur J Echocardiogr, V3, P233, DOI 10.1053/euje.2002.0144
[5]   Cardiac pseudoturnor revealing Behcet's disease [J].
Darie, C ;
Knezinsky, M ;
Demolombe-Rague, S ;
Pinède, L ;
Périnetti, M ;
Ninet, JF ;
Ninet, J .
REVUE DE MEDECINE INTERNE, 2005, 26 (05) :420-424
[6]  
Filali Ansari N, 1999, ANN MED INTERNE PARI, V150, P178
[7]  
HAMZA M, 1987, SEM HOP PARIS, V63, P1195
[8]   Behcet's disease in Tunisia. Clinical study of 519 cases [J].
Hamzaoui, S. B'chir ;
Harmel, A. ;
Bouslama, K. ;
Abdallah, M. ;
Ennafaa, M. ;
M'rad, S. ;
Ben Dridi, M. .
REVUE DE MEDECINE INTERNE, 2006, 27 (10) :742-750
[9]   Association of pulmonary artery aneurysm, right heart thromboses and antiphospholipid antibodies in Behcet's disease. A case report [J].
Harmouche, H ;
Mezalek, ZT ;
Adnaoui, T ;
Aouni, M ;
Mohattane, A ;
Maaouni, A ;
Berbich, A .
REVUE DE MEDECINE INTERNE, 1998, 19 (07) :512-515
[10]   Human α-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behcet's disease [J].
Lee, KH ;
Chung, HS ;
Kim, HS ;
Oh, SH ;
Ha, MK ;
Baik, JH ;
Lee, S ;
Bang, D .
ARTHRITIS AND RHEUMATISM, 2003, 48 (07) :2025-2035